CIK 0001673772
RAPT RAPT Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Dec 23, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at RAPT Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 18 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | Column Group IV, LP owner | JOther Common Stock | -1,352,008 | - | - | 50,000 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group II GP, LP owner | JOther Common Stock | -1,352,008 | - | - | 50,000 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group II GP, LP owner | JOther Common Stockindirect: See footnote | -1,599,417 | - | - | 0 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group IV, LP owner | JOther Common Stockindirect: See footnote | -1,599,417 | - | - | 0 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group II GP, LP owner | JOther Warrant (right to purchase)derivative | +1,352,008 | - | - | 1,352,008 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group IV, LP owner | JOther Warrant (right to purchase)derivative | +1,352,008 | - | - | 1,352,008 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group II GP, LP owner | JOther Warrant (right to purchase)derivativeindirect: See footnote | +1,599,417 | - | - | 1,599,417 | Dec 23, 2024 |
| Dec 23, 2024 | Column Group IV, LP owner | JOther Warrant (right to purchase)derivativeindirect: See footnote | +1,599,417 | - | - | 1,599,417 | Dec 23, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -55,000 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -56,000 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +56,000 | $0.00 | $0 | 56,000 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -75,000 | $0.00 | $0 | 0 | Nov 15, 2024 |
| Nov 13, 2024 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Nov 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICER
- Column Group II GP, LPowner
- Column Group IV, LPowner
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.